No inward currents were observed when o was lowered from the control amount of 140 mM to 130 mM
bitor PLX4720 and MEK inhibitors in CCLE-SkinGlioma; ERBB2 as a predictor for sensitivity to Lapatinib in CCLE-BreatOvary; ABL1 for sensitivity to ABL1 inhibitors in CCLE-Blood. This highlights CHER's ability to…